Our team to fight AMR

Co-founder and CEO

Maxime Fontanié

Maxime is an entrepreneur with a degree in engineering and an executive MBA. He has a broad expertise in pharmaceutical R&D, biotechnology, strategy and business development. Maxime began his career at INSERM (french academic institute). In 2002, he moved to Sanofi where he conducted numbers of drug development as team leader, international Projet Manager, and pharmacologist scientist. Maxime cofounded Vibiosphen in 2014 and Enterosys in 2017.

Co-founder and CSO

Dr Patricia Martin

Dr. Patricia Martin has a solid background in molecular microbiology in the context of the pathophysiology of infectious diseases.
After a thesis on the genomic instability of an antibiotic-producing bacterium, she turned to study the pathogenicity of bacteria, such as meningococcus in Oxford then in Paris and Escherichia coli in Toulouse. During this academic career she acquired skills in project management, team management and communication.
She is holding Vibiosphen as Chief Scientific Officer.
Patricia Martin is the author of 34 international publications, 2 patents and is authorized to supervise research.

Co-founder and COO

Robin Dumas

Robin is in charge of VIKYNG-AI development on national and international territory through strategic partnership . He has a scientific background thanks to his master degree in biotechnology and an MS in technological innovation. He has an experience in business development in small and medium biotechnological companies in France and in the US (San Diego). He is responsible for the business development,collaborative R&D and operations at VIKYNG-AI.

R&D project manager

Nathan Giorgio

Nathan has a strong background in chemical engineering with a specialization in project management. He’s also acquired a rich industrial experience through his previous positions at Sanofi or Boehringer Ingelheim. He has gained a global life cycle vision of a pharmaceutical product, from the production of active pharmaceutical ingredients to the formulation of final products. Nathan has been recruited as R&D project manager and will manage the roadmap of our medical device application.